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Abstract
Microenvironment plays an important role in cancer development. We have reported that the cancer-associated stromal
cells exhibit phenotypic and functional changes compared to stromal cells neighboring to normal tissues. However, the
molecular mechanisms as well as the maintenance of these changes remain elusive. Here we showed that through co-
culture with breast cancer cells for at least three to four passages, breast normal tissue-associated fibroblasts (NAFs) gained
persistent activity for promoting cancer cell invasion, partly via up-regulating ADAM metallopeptidase with
thrombospondin type 1 motif, 1 (ADAMTS1). Furthermore, we demonstrated that the DNA methylation pattern in the
ADAMTS1 promoter has no alteration. Instead, the loss of EZH2 binding to the ADAMTS1 promoter and the resulting
decrease of promoter-associated histone H3K27 methylation may account for the up-regulation of ADAMTS1. Importantly,
the lack of EZH2 binding and the H3K27 methylation on the ADAMTS1 promoter were sustained in cancer cell-
precocultured NAFs after removal of cancer cells. These results suggest that cancer cells are capable of inducing stromal
fibroblasts to secrete ADAMTS1 persistently for their invasion and the effect is epigenetically inheritable.
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Introduction
Cancer development not only depends on the accumulation of
genetic mutations in cancer cells, but also the interaction between
cancer cells and their surrounding stroma. The tumor stroma
including extracellular matrix (ECM), endothelial cells, pericytes,
inflammatory cells and fibroblasts has been shown to assist cancer
progression [1,2,3]. The cancer-associated stromal cells exhibit
phenotypic and functional changes, as well as alterations in gene
expression, compared to stromal cells neighboring to normal
tissues [4,5]. However, the molecular basis for these changes
remains elusive. Nor do we understand in details how stromal
fibroblasts facilitate cancer cell function. Our previous study
suggests that the hepatocyte growth factor (HGF) released by the
breast normal tissue-associated fibroblasts (NAFs) co-cultured with
breast cancer cells is one of the contributing factors [4]. We also
demonstrated that the HGF secretion, once established, can be
maintained in NAFs without the continued co-culture with cancer
cells [4]. Whether the maintenance requires epigenetic mechanism
is not known.
ADAMTS1 has been shown to degrade ECM proteins such as
aggrecan, versican and nidogen-1/-2 [6,7,8]. It helps the shedding
of the extracellular membrane-bound proteins including heparin-
binding epidermal growth factor-like growth factor and amphir-
egulin to activate EGF receptors [9,10]. In addition, it cleaves
membrane-associated syndecan-4 to disrupt cell adhesion and
facilitate cell migration [11]. ADAMTS1 expression in cancer cells
is capable of increasing tumor growth and cancer cell metastasis
[10,12].
In this communication, we show that, in addition to producing
HGF for cancer cell growth [4], NAFs co-cultured with breast
cancer cells also secreted ADAMTS1 for cancer cell invasion.
Most importantly, we found that the above phenomenon can be
maintained through an epigenetic mechanism.
Results
Breast cancer cells stimulated co-cultured fibroblasts to
promote cancer cell invasion
Our previous study has established a system in which NAF
200N was co-cultured with breast cancer MDA-MB-468 cells [4]
(Fig. 1A). After co-incubation for 3.5 days, 200N cells were isolated
and marked as 200N.E1.P0. Some of 200N.E1.P0 was propagated
without MDA-MB-468 co-culture for further passages (P1, P2 and
P3); others were continuously co-cultured with MDA-MB-468 to
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e35128generate 200N.E2.P0, 200N.E3.P0 and 200N.E4.P0. These cells
were again cultured with the removal of MDA-MB-468 for further
passages P1, P2 and P3. 200N and its derivatives were then
assayed for the ability in cancer cell invasion. The results
demonstrated that the conditional medium derived from
200N.E4.P3 contained a higher activity in promoting invasion of
MDA-MB-468 cells, compared to 200N (200N.P10) (Fig. 1B, left
panel). Importantly, the invasion promoting capability of
200N.E4.P3 was comparable to that of cancer tissue-associated
fibroblasts (CAF, 199C.P10). In contrast, 200N.E1-E3.P3 did not
show increased activities for cell invasion (Fig. 1B, left panel).
Similar results were observed when the other breast cancer MDA-
MB-231 cells were used for invasion assay (Fig. 1B, right panel).
These experiments indicate that cancer cells are able to stimulate
normal tissue-associated fibroblasts to facilitate cell invasion, and
that the effect requires a certain period of time of NAF co-culture
with cancer cells before it can be established.
Breast cancer cells induced ADAMTS1 expression in the
co-cultured fibroblasts
Our results above suggest that paracrine signaling may be
involved in the breast cancer cell invasion by the co-cultured
fibroblasts. To identify the fibroblast-secreted factors that
contribute to cancer cell progression, we compared gene
expression profiles in CAF 199C, NAF 200N and NAF
200N.E1-E4.P3 using cDNA microarray analysis. Particular
interests were paid to genes encoding secreted proteins and genes
only upregulated in 199C.P10 and 200N.E4.P3 as these two cell
lines show the ability to promote cancer cell invasion. Several
factors including serglycin (SRGN) and ADAMTS1 (Table 1) were
initially identified, but only these two genes were confirmed in
199C/200N using quantitative real-time RT-PCR analysis (Fig. 2A
and Fig. S1). ADAMTS1 was chosen for this study due to its
reported essential role in cancer metastasis [10]. Further
comparative analysis of total 10 pairs of CAF/NAF from breast
cancer patients revealed that the expression of ADAMTS1 in
CAFs was relatively higher than in NAF (Fig. 2A).
To conform whether ADAMTS1 expression is correlated to the
invasion ability, the co-cultured NAF derivatives from Fig. 1B
were analyzed. The co-cultured derivative 200N.E4.P3 produced
high level of ADAMTS1 mRNA only after four consecutive co-
cultures with MDA-MB-468 cells (Fig. 2B). In addition to 200N,
the up-regulation of ADAMTS1 expression was also observed in
other normal tissue-associated fibroblasts from two patients, 245N
and 260N, after four consecutive co-cultures with MDA-MB-468
cells (Fig. 2C, 245N.E4.P3 and 260N.E4.P3). These results
indicate that breast cancer cells are able to induce ADAMTS1
expression in the co-cultured fibroblasts. Consistently, the levels of
total ADAMTS1 protein and the secreted ADAMTS1 were
increased in 199C.P10 and 200N.E4.P3, but not 200N.P10 or
200N.E1-3.P3 (Fig. 2D and 2E). It should be noted that the
ADAMTS1 doublet in Figure 2D likely represents differently
posttranslationally modified forms of the protein. The lower band
is ADAMTS1 (around 87 kD) and the upper band is the N-
glycosylated form of ADAMTS1, as suggested [13]. To further
confirm the induction of ADAMTS1 is not only specific to NAFs
co-cultured with MDA-MB-468, NAF 200N co-cultured with
another breast cancer cell line SK-BR-3 was analyzed. Similarly,
ADAMTS1 mRNA level was increased in SK-BR-3 cell-
precocultured NAF 200N.S4.P3, but not 200N.S1-S3.P3, com-
pared to 200N.P10 (Fig. 2F). These results demonstrated that
breast cancer cell-mediated ADAMTS1 induction in NAFs is
likely a common event.
ADAMTS1 secreted from fibroblasts enhanced cancer cell
invasion
Subsequently we examined the cancer invasion promotion
function of ADAMTS1 secreted from fibroblasts. To this purpose,
ADAMTS1 Ab was added into the conditional medium derived
from CAF 199C, followed by invasion assays. As shown in Fig. 3A,
blocking of ADAMTS1 with the corresponding antibodies greatly
impaired 199C’s cancer invasion promotion function on both
MDA-MB-468 and MDA-MB-231 cells in an ADAMTS1 Ab
dose-dependent manner (Fig. 3A). Consistently, ADAMTS1 Ab
also suppressed NAF 200N.E4.P3-mediated invasion of breast
cancer cells (Fig. 3B). To further confirm the specificity of
ADAMTS1 in the invasion promotion function, we also knocked
down ADAMTS1 expression in CAF 199C using a shRNA
lentiviral system (Fig. 3C) and found that ADAMTS1 depletion
significantly reduced CAF 199C-mediated cancer invasion
(Fig. 3D). In agreement with these results, overexpression of
ADAMTS1 enhanced the invasion function of NAF 200N
(Fig. 3E). Taken together, these experiments strongly indicate that
fibroblasts promote cancer cell invasion through secreting
ADAMTS1.
ADAMTS1 expression in cancer-associated fibroblasts
positively correlated with metastasis
Given that cancer-associated fibroblasts secrete ADAMTS1 for
cancer cell invasion, it’s likely that the expression of ADAMTS1 in
CAFs is physiologically relevant to breast cancer progression. To
test this possibility, we analyzed ADAMTS1 mRNA of CAFs from
49 breast cancer patients and found that the higher expression of
ADAMTS1 mRNA of CAFs in patients was significantly
correlated with lymph node metastasis (Fig. 4A). Further detailed
analysis by subdividing patients with degree of metastasis versus
ADAMTS1 mRNA level revealed a similar significant correlation
(Fig. 4B). These results indicated that ADAMTS1 expression in
cancer-associated fibroblasts positively correlates with metastasis
and thus may play an important role in breast cancer progression.
The heritable increase of ADAMTS1 expression in cancer
cell-precocultured fibroblasts correlated with reduction
of ADAMTS1 promoter-associated H3K27me3 and EZH2
binding
Finally, we investigated the mechanism by which ADAMTS1
was activated in NAF co-cultured with breast cancer cells. It
should be noted that the induced expression of ADAMTS1 indeed
was observed in NAF after 4 consecutive co-incubations with
breast cancer cells and the following removal of breast cancer cells
for 3 passages (ex, 200N.E4.P3). It’s not known whether
ADAMTS1 was upregulated in passages before P3 or still
sustained after P3. Analysis of ADAMTS1 gene expression in
200N.E4.P0-P5 indicated that the ADAMTS1 mRNA level was
gradually increased from P1 to P2, followed by a sharp induction
in P3 (Fig. 5A). Interestingly, the ADAMTS1 mRNA level in P5
was comparable to P3, indicating that ADAMTS1 induction, once
established, could be maintained (Fig. 5A). In contrast, the
ADAMTS1 expression in 200N.E1-E3.P0-P5 or the parental
200N.P7-P15 was minimally activated (Fig. 5A).
Next, the potential mechanism involved in the sustained
expression of ADAMTS1 in NAFs after removal of the co-
cultured breast cancer cells was explored. First, we analyzed if the
DNA methylation level of the ADAMTS1 promoter in
200N.E4.P3 or 199C.P10 was lower than in 200N.P10. DNA
methylation correlates with gene repression and is heritable
through recognition of the hemi-methylated DNA and methyla-
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DNA methyltransferase 1 during DNA replication [14]. As shown
in Fig. 5B, the methylated DNA immunoprecipitation (MeDIP)
assays indicated that no significant change in DNA methylation
was observed. The methylation of the promoter of H19, an
imprinted gene permanently silenced in the paternal allele in
somatic cells [15], and the promoter of ubiquitin-conjugating
enzyme E2B (UBE2B), a constitutively active gene [16], was
examined as positive and negative controls for MeDIP, respec-
tively. The analysis revealed that the DNA methylation level in
ADAMTS1 promoter was comparable to the low level in UBE2B
gene in both 200N.P10 and 199C.P10 (Fig. S2). The bisulfite
sequencing further confirmed the hypomethylation of ADAMTS1
promoter in 199C.P10, 200N.P10 and 200N.E4.P3 (Fig. 5C).
Thus, it’s unlikely that DNA methylation governs the differential
expression of ADAMTS1 in cancer-associated fibroblasts.
In addition to DNA methylation, specific histone modifications
also correlate with gene expression, although their heritable roles
are still unsettled [17]. A panel of ADAMTS1 promoter-associated
histone modifications was analyzed in 200N.P10, 199C.P10, and
200N.E4.P3 using chromatin immunoprecipitation assays with
antibodies against acetylated H3, H3 tri-methylated at K4, K9,
K27, K36, or K79, or the histone methyltransferase EZH2. Note
that H3 acetylation, trimethylation of H3 at K4, K36 and K79 are
generally associated with gene activation, while trimethylation of
H3 at K9 and K27 correlates with gene repression [18,19,20]. As
shown in Fig. 5D, only ADAMTS1 promoter-associated H3K27
trimethylation was reduced in 199C.P10 and 200N.E4.P3,
Figure 1. Pre-coculture with breast cancer cells enhanced fibroblast’s ability to promote cancer cell invasion. (A) The diagram of the
co-culture protocol. NAF 200N.P7 co-cultured with MDA-MB-468 cells for four passages is indicated as 200N.E1-E4, respectively. Each of 200N.E1-E4
was propagated in the absence of MDA-MB-468 cell for passages from P1 to P3. (B) The conditional media derived from CAF 199C.P10 and cancer
cell-precocultured NAF 200N.E4.P3 enhanced the invasion ability of MDA-MB-468 cells and MDA-MB-231 cells. Data are shown as mean 6 SD from
triplicate experiments. Statistical significance was evaluated by Student’s t-test. * P,0.05.
doi:10.1371/journal.pone.0035128.g001
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associated binding of EZH2, the histone methyltransferase for
H3K27 trimethylation, was also significantly reduced (Fig. 5D).
The quantitative ChIP results of Fig. 5, shown by pull-down
percentage, are now displayed in Fig. S3. Furthermore, the
reduction of the EZH2 binding was not due to decreased EZH2
expression in 200N.E4.P3 (Fig. S4). Most importantly, the
decrease of both H3K27me3 and EZH2 binding on the
ADAMTS1 promoter could be sustained through passages to
200N.E4.P5 (Fig. 5E). These results indicated that the heritable
increase of ADAMTS1 expression in fibroblasts pre-cocultured
with cancer cells is likely mediated by the reduction of ADAMTS1
promoter-associated EZH2 binding and the resulting loss of
H3K27me3.
Figure 2. Pre-coculture with breast cancer cells increased ADAMTS1 mRNA levels in NAFs. (A–C) Quantitative real-time RT-PCR analysis
revealed that ADAMTS1 mRNA levels were higher in CAFs than in the corresponding NAFs in ten breast cancer patients (A), and that ADAMTS1 mRNA
levels in CAF 199C.P10 and NAF 200N.E4.P3 were higher than in NAF 200N.P10 and 200N.E1-E3.P3 (B). Similar results are shown using the pairs of CAF
244C/NAF 245N and CAF 259C/NAF 260N (C). (D) The ADAMTS1 protein level in NAF 200N.E4.P3, but not NAF 200N.E1-E3.P3, was enhanced to the
similar level in CAF 199C.P10, compared to NAF 200N.P10. (E) ELISA indicated that the ADAMTS1 protein level in cultured medium derived from NAF
200N.E4.P3 was higher than NAF 200N.E1-E3.P3 and NAF 200N.P10. (F) ADAMTS1 mRNA level in SK-BR-3 cell-precocultured NAF 200N.S4.P3 was also
higher than in NAF 200N.P10 and 200N.S1-S3.P3. Data are shown as mean 6 SD from triplicate experiments. Statistical significance was evaluated by
Student’s t-test. * P,0.05.
doi:10.1371/journal.pone.0035128.g002
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The current report demonstrates that cancer-associated fibro-
blasts (CAFs) secreted ADAMTS1 to promote cancer cell invasion
(Fig. 3). We further show that the level of the CAF-secreted
ADAMTS1 significantly correlates with lymph node metastasis of
breast cancer patients (Fig. 4). Indeed, a previous study has
revealed a role of cancer cell-expressed ADAMTS1 in metastasis
with a mechanism involving activation of epidermal growth factor
receptor and ErbB-2 and shedding of amphiregulin and heparin-
bound epidermal growth factor precursors [10]. Interestingly, we
found that both the mRNA and protein levels of ADAMTS1 in
CAFs are much higher than those in cancer cells such as MDA-
MB-468 and MDA-MB-231 (Fig. S5). Given that CAF-secreted
ADAMTS1 exhibits promotion ability for cancer invasion (Fig. 3),
it’s highly possible that ADAMTS1 secreted from CAFs
contributes more than that from cancer cells to facilitate cancer
invasion.
Our study further points out that the activation of ADAMTS1
in CAFs can be recapitulated in normal tissue-associated
fibroblasts (NAFs) after their co-culture with breast cancer cells
(Fig. 2), and that ADAMTS1 stimulation in cancer cell-cocultured
NAFs can be sustained after the removal of the co-cultured cancer
cells (Fig. 2). The latter observation is particularly intriguing. To
explore the underlying mechanism, we investigated two most well
studied causes for gene repression: DNA methylation and histone
methylation. It was found that the sustained ADAMTS1
upregulation in NAFs precocultured with cancer cells correlates
with an epigenetic mechanism involving the loss of ADAMTS1
promoter-associated EZH2 binding and the corresponding
H3K27 trimethylation (Fig. 5). In contrast, DNA methylation
does not seem to participate in the event (Fig. 5B, 5C, and S2).
Although ADAMTS1 promoter has been shown to contain CpG
islands which are hypermethylated in colorectal cancer [21], our
bisulfite sequencing and MeDIP results indicate that ADAMTS1
promoter is indeed hypomethylated in breast cancer-associated
fibroblasts, normal breast tissue-associated fibroblasts or NAFs co-
cultured with breast cancer cells (Fig. 5B, 5C and S2). Thus, it’s
very likely that the change in H3K27 trimethylation, rather than
DNA methylation, governs this epigenetic memory, which
contributes to the sustained expression of ADAMTS1 in cancer
cell-precocultured NAFs. These results are also consistent with
previous observations in which DNA methylation and H3K27
methylation, though both are correlated with gene repression,
separately control independent subsets of genes [22,23,24,25].
Since histone methylation is a balanced reaction carried out by
histone methyltransferases and demethylases, the possibility that
H3K27 demethylases such as UTX and JMJD3 [26,27] may be
used to remove the methyl marks from ADAMTS1 promoter
cannot be excluded.
Importantly, we found that H3K27me3 is also reduced in the
promoter of serglycin, a proteoglycan [28], in 199C.P10 and
200N.E4.P3 where serglycin mRNA level is increased (Table 1,
Fig. S1 and S6). This suggests that loss of the transcriptional
repression mark H3K27me3 is likely a common mechanism to
derepress genes essential for cancer promotion function of cancer
cell-associated fibroblasts.
How ADAMTS1 expression is induced following co-culture
with breast cancer cells remains to be resolved. The mechanism,
which prevents EZH2 from binding to ADAMTS1 promoter in
cancer cell-precocultured NAFs, is currently under investigation. A
previous report has shown that overexpression of Akt in breast
cancer cells renders EZH2 phosphorylated at Ser 21 and results in
the loss of EZH2 binding to its target promoters [29]. Consistently,
our preliminary data that LY294002, an inhibitor of PI3K-Akt
signaling pathway, significantly diminished ADAMTS1 activation
in cancer cell-precocultured NAF, suggesting that PI3K-Akt
signaling may mediate the initial step to down-regulate the
binding of EZH2 to ADAMTS1 promoter (data not shown).
Furthermore, it remains obscure what kind of factors secreted
from breast cancer cells is responsible for ‘‘educating’’ NAFs either
directly or indirectly. This process is of great interest for further
pursuing. Given the increased expression of ADAMTS1, the
altered histone methylation at the ADAMTS1 promoter is not
particularly surprising. Indeed, the most intriguing question is how
the loss of EZH2 binding to ADAMTS1 promoter is sustained in
cancer cell-cocultured NAFs after the removal of cancer cells.
Currently, there is little clue to address this issue. Nevertheless, the
system described here provides a potential venue to demystify how
epigenetic change becomes inheritable.
Materials and Methods
Ethics statement
All human specimens were encoded to protect patient
confidentiality and processed under protocols approved by the
Institutional Reviews Board of Human Subjects Research Ethics
Committee of Academia Sinica (AS-IRB02-98042) and National
Taiwan University Hospital (#200902001R), Taipei, Taiwan.
Breast cancer tissues and its relative normal counterparts were
obtained from patients who underwent surgery at National
Taiwan University Hospital. Signed consent for the studies was
obtained from all the patients.
Clinical specimens and cell cultures
Human breast cancer tissues and its relative normal counter-
parts were minced to 2–3 mm
3 cubes and attached onto the
culture dishes for fibroblast culture. Primary fibroblasts isolated
from clinical specimens were maintained in Dulbecco’s Modified
Eagle’s Medium/F-12 Nutrient Mixture (DMEM/F-12) (Invitro-
gen) supplemented with 10% fetal bovine serum (Industrial
Biological), 0.1 mM non-essential amino acids and 1 mM sodium
pyruvate (Invitrogen). Breast cancer cell lines, MDA-MB-468,
MDA-MB-231 and SK-BR-3, were cultured in DMEM/F-12,
supplemented with 10% fetal bovine serum.
Table 1. Relative gene expression of serglycin and ADAMTS1.
Gene Name 199C.P10 200N.P10 200N.E1.P3 200N.E2.P3 200N.E3.P3 200N.E4.P3
Serglycin 3.85 1.00 1.30 0.80 1.04 2.69
ADAMTS1 1.69 1.00 1.30 0.95 0.92 2.56
Relative gene expression levels of secreted proteins up-regulated in 199C and 200N.E4.P3. The results of cDNA microarray analysis show that serglycin and ADAMTS1
are induced in CAF 199C.P10 and MDA-MB-468 cell-precocultured NAF 200N.E4.P3, compared to NAF 200N.P10.
doi:10.1371/journal.pone.0035128.t001
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Lentivirus-based shRNA plasmids for knocking down
ADAMTS1 expression were provided by National RNAi Core
Facility, Taiwan. The target sequences were 59-CCA GCA TTC
GTA ATT CAG TTA-39 (sh#1), 59-CCA CAG GAA CTG GAA
GCA TAA-39 (sh#2) and 59-CCA CCT TAG AGC AAG ACA
TTA-39 (sh#3). Viral infection was performed following the
procedures provided by National RNAi Core Facility. ADAMTS1
cDNA was derived and amplified from Origene’s human full-
length cDNA collection using the following primers: 59-CGA TCT
CGA GAT GCA GCG AGC TGT GCC CG-39 and 59-CGA
TTC TAG ATT AAC TGC ATT CTG CCA TTG TG-39. The
amplified DNA fragment was subcloned into pLVX-IRES-Neo
vector using restriction endonuclease XhoI and XbaI for
expression through a Lenti-X expression system (Clontech).
Co-culture of fibroblasts with cancer cells
Co-culture of fibroblasts with cancer cells was performed using a
transwell system as described by Tyan et al. [4]. In the co-culture
system, 8610
4 NAF 200N.P7 cells were grown in the bottom of a
Figure 3. ADAMTS1 secreted from stromal fibroblasts enhanced cancer cell invasion. (A) Sequestration of the ADAMTS1 activity in the
conditional medium derived from CAF 199C.P10 using an anti-ADAMTS1 antibody reduced invasion ability of MDA-MB-468 cells (left) and MDA-MB-
231 cells (right) in an anti-ADAMTS1 Ab dose-dependent manner. (B) Neutralization of the ADAMTS1 activity in the conditional medium derived from
NAF 200N.E4.P3 using an anti-ADAMTS1 antibody also reduced invasion ability of MDA-MB-468 cells (left) and MDA-MB-231 cells (right). (C) Western
shows the efficient inhibition of ADAMTS1 protein level by three independent shRNAs. (D) The conditional medium derived from CAF 199C.P10
depleted of ADAMTS1 by shRNAs exhibited significantly lower activity for invasion of MDA-MB-468 cells (left) and MDA.MB-231 cells (right). (E) The
conditional media derived from NAF 200N.P10 with exogenous ADAMTS1 expression (left, western) enhanced invasion of MDA-MB-468 cells (middle)
and MDA-MB-231 cells (right). Data are shown as mean 6 SD from triplicate experiments. Statistical significance was evaluated by Student’s t-test.
* P,0.05.
doi:10.1371/journal.pone.0035128.g003
Figure 4. ADAMTS1 expression in CAF correlated with lymph node metastasis. (A) A scatter dot plot of ADAMTS1 mRNA levels in CAFs
assessed using quantitative real-time RT-PCR analysis. The ADAMTS1 mRNA levels in CAFs of patients with lymph node metastasis (n=27) were
significantly higher than in those of patients without lymph node metastasis (n=22) (P=0.0003). Data are shown as mean 6 SD of triplicate samples.
Statistical significance was evaluated by Student’s t-test. *** P,0.001. (B) The relationship between ADAMTS1 expression and lymph node metastasis
was analyzed using Fisher’s exact test. ADAMTS1 expression levels in CAFs derived from patients with $60% lymph node metastasis were
significantly higher than those of patients with #60% lymph node metastasis or with zero lymph node metastasis (P=0.001). Relative quantity (RQ)
of ADAMTS1 expression compared to beta-actin expression: +, 0.001#RQ#0.025; ++, 0.025,RQ,0.051; +++,R Q $0.051.
doi:10.1371/journal.pone.0035128.g004
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PLoS ONE | www.plosone.org 7 April 2012 | Volume 7 | Issue 4 | e35128Figure 5. Increase of ADAMTS1 mRNA correlated with reduction of ADAMTS1 promoter-associated H3K27me3 and EZH2 binding
through passages. (A) ADAMTS1 mRNA levels in indicated NAF derivatives were analyzed and shown gradually increased in NAF 200N.E4 from P0
to P3 and maintained from P3 to P5. (B) MeDIP indicates that ADAMTS1 promoter-associated DNA methylation level was similar in NAF 200N.P10, CAF
199C.P10 and NAF 200N.E4.P3 cells. (C) Bisulfite sequencing indicates that ADAMTS1 promoter in CAF 199C.P10, NAF 200N.P10 and NAF 200N.E4.P3
cells was hypomethylated. Closed circle: methylated cytosine. (D) ADAMTS1 promoter-associated H3K27me3 and EZH2 binding was decreased in CAF
199C.P10 and NAF 200N.E4.P3 cells. (B and D) MeDIP (B) or ChIP assays (D) using antibody against H3ace, H3K4me3, H3K9me3, H3K27me3,
H3K36me3, H3K79me3 or EZH2 was performed in NAF 200N.P10 (white bars), CAF 199C.P10 (black bars) and NAF 200N.E4.P3 (gray bars) cells,
followed by real-time PCR analysis. (E) ADAMTS1 promoter-associated H3K27me3 and EZH2 binding were decreased in NAF 200N.E4.P3 and
maintained through passages to NAF 200N.E4.P5. ChIP assays using antibody against H3K27me3 (black bars) or EZH2 (white bars) were performed in
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serum and 1610
5 MDA-MB-468 cells were seeded onto the 0.4-
mm polyester membrane of a transwell insert (Corning) in 1.5 ml of
the same medium. NAF 200N.E1.P0 was derived after incubation
of the co-cultured cells for 78 h in a humidified incubator with 5%
CO2 at 37uC. NAF 200N.E1.P0 fibroblasts were subcultured and
grown for generation of passages P1, P2 and P3 without MDA-
MB-468 cell co-culture; others were subcultured and continued to
co-culture with MDA-MB-468 cells for 78 h to generate NAF
200N.E2.P0. NAF 200N.E3.P0 and NAF 200N.E4.P0 and their
P1 to P3 derivatives were obtained following the same procedure
described above.
Invasion assay
10
4 of MDA-MB-468 or MDA-MB-231 cells were suspended in
100 ml of the 24 h-cultured media collected from indicated
fibroblast derivatives at 100% confluency. The mixtures were
subsequently added onto the upper chamber of a transwell
apparatus containing an insert with a proprietary light-opague
PET membrane of 8-mm pore size (Falcon #351152) and coated
with 15 mlo f3 0mg matrigel matrix (BD #354234). The lower
chamber was added with 500 ml of medium containing 10% FBS.
The cells were incubated for 16 h or 36 h for MDA-MB-231 or
MDA-MB-468 cells, respectively. The invading cells on the lower
surface of membrane were fixed with methanol for 20 min,
washed twice with PBS for 5 min, stained with DAPI (1:10000) for
5 min, and examined and counted with fluorescence microscopy.
For the purpose of neutralizing ADAMTS1 activity, 0.3–7.5 mg
of mouse monoclonal anti-human ADAMTS1 antibody (R&D
Systems) or mouse IgG2B (R&D Systems) was added to 100 mlo f
100% confluent fibroblast-cultured medium. The medium was
then mixed with MDA-MB-468 or MDA-MB-231 cells before the
invasion assays were performed.
Quantitative real-time RT-PCR
Total RNAs from fibroblasts were isolated using TRI reagent
(Ambion). One mg of purified RNA was subjected to cDNA
synthesis by Superscript II reverse transcriptase (Invitrogen) in
20 ml of reaction buffer according to the manufacturer’s protocol,
followed by real-time PCR analysis using the ABI PRISM 7000
sequence detection system with SYBER Green method (Applied
Biosystems) according to the manufacturer’s instruction. The
primers used were: ADAMTS1: 59-ACG AGT GCG CTA CAG
ATC CT-39 and 59-CAG CGT ACT TGG GAA TCC AT-39;
SRGN: 59-CGC TGC AAT CCA GAC AGT AA-39 and 59-CCT
GGA TTC TCG TCT TTG GA-39; the internal control, beta-
actin: 59-ATC TGG CAC CAC ACC TTC TAC A-39 and 59-
TCA CCG GAG TCC ATC ACG AT-39. The amplification
mixture contained 1 mlo f5 6 diluted reverse transcription
product, 200 nM of each primer, 250 nM probe, and 12.5 mlo f
26SYBER Green PCR master mix (Applied Biosystems) in a total
of 20-ml reaction volume. The thermal conditions were: 2 min at
50uC and 10 min at 95uC, followed by 40 cycles at 95uC for
15 sec and 55uC for 1 min. The relative quantity of mRNA was
estimated by using a standard curve created by serial dilution of
the reverse transcription products from NAFs.
Western blotting analysis
Fibroblasts were grown to 100% confluency and replaced with
fresh medium one day before protein extraction with RIPA buffer
containing 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1%
IGEPAL CA-630, 2 mM EDTA and protease inhibitors with
thorough homogenization. Lysates were centrifuged and the
supernatant with 30 mg of protein content was resolved by SDS-
8% PAGE, followed by protein transfer to the PVDF membrane
and immunoblotting of the membrane with mouse monoclonal
anti-human ADAMTS1 (GeneTex), anti-alpha tubulin (GeneTex)
or rabbit polyclonal anti-EZH2 (Diagenode) antibody. The
secondary antibody used was horseradish peroxidase (HRP)-
conjugated horse-anti-mouse IgG (Cell Signaling) or HRP-
conjugated donkey-anti-rabbit IgG (GE Healthcare). Membranes
were developed by reacting with chemiluminescent HRP substrate
and exposed to BioSpectrumAC imaging system (Ultra-Violet
Products).
Enzyme-linked immunosorbent assay (ELISA) to quantify
the secreted ADAMTS1
Fibroblasts were grown to 100% confluency and replaced with
fresh medium one day before the assay. The cultured medium was
centrifuged at 3006g for 5 min. 100 ml of the supernatant was
subjected to enzyme-linked immunosorbent assay for ADAMTS1
(Uscn Life Science) following the manufacturer’s instruction.
Methylated DNA immunoprecipitation (MeDIP) assay
Genomic DNA was prepared using QIAamp DNA mini kit
(Qiagen) and sonicated using Bioruptor sonication device
(Diagenode) to produce random fragments ranging in mean size
from 300 to 1,000 bp. 5 mg of fragmented DNA was denatured for
10 min at 95uC and immunoprecipitated overnight at 4uC with
5 ml of 5-methylcytidine antibody (Eurogentec) in a final volume of
500 ml IP buffer [10 mM sodium phosphate (pH 7.0), 140 mM
NaCl, 0.05% Triton X-100]. The mixture was incubated with
30 ml magnetic beads (Millipore) for another 4 h at 4uC and
washed three times with 1 ml of IP buffer. Beads were
resuspended with 250 ml digestion buffer (50 mM Tris pH 8.0,
10 mM EDTA, 0.5% SDS) containing 0.4 mg/ml protease K and
shaken overnight at 56uC. DNA was extracted using QIAquick
PCR purification kit (Qiagen) and subjected to real-time PCR
analysis using the Roche Light Cycler 480 real-time PCR system
with SYBER Green method (Roche) according to the manufac-
turer’s instruction. Primers for ADAMTS1 promoter from
2431,2217 bp were 59-CCA GGA TAG GGA AAT GTT
GA-39 and 59-TGT GAC CAG CAC TTT GTA CT-39.
Bisulfite sequencing analysis
Genomic DNA was prepared using Genomic DNA mini kit
(Geneaid) and subjected to bisulfite CT conversion reaction using
EZ DNA methylation-Gold kit (ZYMO research). The promoter
and 59-untranslated region of ADAMTS1 was divided into four
fragments, which were amplified from the bisulfite reaction
mixture using the following primers: for nt 2813,2501 region:
59-TTT TTA TGT TTT AGG GAA TTG-39 and 59-AAA AAT
ACC TCA CCC CAC TT-39; for nt 2514,2219 region: 59-
GGT GAG GTA TTT TTT TAG AA-39 and 59-TAA CCA
ACA CTT TAT ACT AC-39 ; for nt -268,+51 region: 59-AGG
cells indicated, followed by real-time PCR analysis. (B, D and E) PCR amplification was performed with DNA primers against the ADAMTS1 promoter
region from 2431 bp to 2217 bp. Data are shown as mean 6 SD from triplicate experiments. Statistical significance was evaluated by Student’s t-
test. * P,0.05. NS: No significant difference.
doi:10.1371/journal.pone.0035128.g005
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TTT ACA ATA AC-39 ; for nt +64,+370 region: 59-GAG AGG
GGA GAG TTT TGA GTA GAG T-39 and 59-ACT CTA AAT
TAT TAA AAT TAA CAA TTT CTA-39. The amplified
fragments were subcloned into pCR2.1-TOPO vector (Invitrogen)
for sequencing analysis.
Chromatin immunoprecipitation (ChIP)
ChIP assays were performed as described by Hsu et al. [30] with
modifications. The antibodies used for immunoprecipitation were
H3ace (Millipore #06-599), H3K4me3 (Abcam #ab1012),
H3K9me3 (Abcam #ab8898), H3K27me3 (Abcam #ab6002),
H3K36me3 (Abcam #ab9050) and H3K79me3 (Abcam
#ab2621). The immunoprecipitated DNA fragments were
extracted using QIAquick PCR purification kit (Qiagen) and
subjected to real-time PCR analysis using the Roche Light Cycler
480 real-time PCR system with SYBER Green method (Roche).
The amplifications with DNA primers against the ADAMTS1and
SRGN promoter region were performed in a reaction volume of
20 ml containing 2 ml of immunoprecipitated material. Primers for
ADAMTS1 promoter from 2431 to 2217 bp were 59-CCA GGA
TAG GGA AAT GTT GA-39 and 59-TGT GAC CAG CAC
TTT GTA CT-39. Primers for SRGN promoter from 2149 to
219 bp were 59-GGA GTC CAG TAC AGT TTC ATA AT-39
and 59-TGC CCA GAA CAC ACG TCA-39.
Supporting Information
Figure S1 Quantitative real-time RT-PCR analysis
shows that serglycin, which was highly expressed in
CAF 199C.P10 compared to NAF 200N.P10, was induced
in MDA-MB-468 cell-precocultured NAF 200N.E4.P3, but
not in 200N.E1-E3.P3.
(TIF)
Figure S2 Quality controls for methylated DNA immu-
noprecipitation (MeDIP). MeDIP was applied with PCR
primers to amplify the promoter region of ADAMTS1, H19, an
imprinted gene permanently silenced in somatic cells, or ubiquitin-
conjugating enzyme E2B (UBE2B), a constitutively active gene in
NAF 200N.P10 (white bars) and CAF 199C.P10 (black bars).
(TIF)
Figure S3 The quantitative ChIP results of Fig. 5, shown
by pull-down percentage.
(TIF)
Figure S4 The protein level of EZH2 is approximately
equal in NAF 200N.P10 and NAF 200N.E4.P3 cells.
Western analysis was performed using antibody against EZH2
or alpha-tubulin.
(TIF)
Figure S5 ADAMTS1 mRNA (A) and protein (B) levels
are high in CAF 199C and NAF 200N, compared to MDA-
MB-468 cells and MDA-MB-231 cells.
(TIF)
Figure S6 Serglycin promoter-associated H3K27me3,
but not H3ace, is reduced in CAF 199C.P10 and NAF
200N.E4.P3, compared to NAF 200N.P10 cells. Chromatin-
immunoprcipitation (ChIP) assays using antibody against H3ace
or H3K27me3 were performed in indicated cells, followed by
PCR amplification with DNA primers against the serglycin
promoter region from 2149 bp to 219 bp. Data are shown as
mean 6 SD from triplicate experiments. Statistical significance
was evaluated by Student’s t-test. * P,0.05.
(TIF)
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